Literature DB >> 1910089

Design and synthesis of HIV protease inhibitors. Variations of the carboxy terminus of the HIV protease inhibitor L-682,679.

S J deSolms1, E A Giuliani, J P Guare, J P Vacca, W M Sanders, S L Graham, J M Wiggins, P L Darke, I S Sigal, J A Zugay.   

Abstract

A series of tetrapeptide analogues of 1 (L-682,679), in which the carboxy terminus has been shortened and modified, was prepared and their inhibitory activity measured against the HIV protease in a peptide cleavage assay. Selected examples were tested as inhibitors of virus spread in cell culture. Compound 12 was a 10-fold more potent enzyme inhibitor than 1 in vitro and 30-fold more potent in inhibiting the viral spread in cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1910089     DOI: 10.1021/jm00113a025

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  3 in total

1.  LUDI: rule-based automatic design of new substituents for enzyme inhibitor leads.

Authors:  H J Böhm
Journal:  J Comput Aided Mol Des       Date:  1992-12       Impact factor: 3.686

Review 2.  Antiviral therapy for human immunodeficiency virus infections.

Authors:  E De Clercq
Journal:  Clin Microbiol Rev       Date:  1995-04       Impact factor: 26.132

3.  Presenilin 1 is linked with gamma-secretase activity in the detergent solubilized state.

Authors:  Y M Li; M T Lai; M Xu; Q Huang; J DiMuzio-Mower; M K Sardana; X P Shi; K C Yin; J A Shafer; S J Gardell
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.